Abstract
Daratumumab is a fully human, monoclonal immunoglobulin G1 and a first-in-class CD38-targeting drug approved by the US Food and Drug Administration fo......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
